Style | Citing Format |
---|---|
MLA | Mirzaei H, et al.. "Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study." Journal of Diabetes and Metabolic Disorders, vol. 21, no. 1, 2022, pp. 483-492. |
APA | Mirzaei H, Siavash M, Shahnazi H, Eslami AA (2022). Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study. Journal of Diabetes and Metabolic Disorders, 21(1), 483-492. |
Chicago | Mirzaei H, Siavash M, Shahnazi H, Eslami AA. "Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study." Journal of Diabetes and Metabolic Disorders 21, no. 1 (2022): 483-492. |
Harvard | Mirzaei H et al. (2022) 'Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study', Journal of Diabetes and Metabolic Disorders, 21(1), pp. 483-492. |
Vancouver | Mirzaei H, Siavash M, Shahnazi H, Eslami AA. Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study. Journal of Diabetes and Metabolic Disorders. 2022;21(1):483-492. |
BibTex | @article{ author = {Mirzaei H and Siavash M and Shahnazi H and Eslami AA}, title = {Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {21}, number = {1}, pages = {483-492}, year = {2022} } |
RIS | TY - JOUR AU - Mirzaei H AU - Siavash M AU - Shahnazi H AU - Eslami AA TI - Development and Evaluation of a New Questionnaire to Assess Social Cognitive Factors of Self-Management in Patients With Type 2 Diabetes: A Psychometric Study JO - Journal of Diabetes and Metabolic Disorders VL - 21 IS - 1 SP - 483 EP - 492 PY - 2022 ER - |